JP2023534241A5 - - Google Patents
Info
- Publication number
- JP2023534241A5 JP2023534241A5 JP2023502572A JP2023502572A JP2023534241A5 JP 2023534241 A5 JP2023534241 A5 JP 2023534241A5 JP 2023502572 A JP2023502572 A JP 2023502572A JP 2023502572 A JP2023502572 A JP 2023502572A JP 2023534241 A5 JP2023534241 A5 JP 2023534241A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063050931P | 2020-07-13 | 2020-07-13 | |
| US63/050,931 | 2020-07-13 | ||
| PCT/US2021/041375 WO2022015694A1 (en) | 2020-07-13 | 2021-07-13 | Hla class ii–restricted drb t cell receptors against ras with g12d mutation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534241A JP2023534241A (ja) | 2023-08-08 |
| JP2023534241A5 true JP2023534241A5 (https=) | 2024-07-18 |
| JPWO2022015694A5 JPWO2022015694A5 (https=) | 2024-07-18 |
Family
ID=77227130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502572A Pending JP2023534241A (ja) | 2020-07-13 | 2021-07-13 | Ｇ１２ｄ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｄｒｂ ｔ細胞受容体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230272038A1 (https=) |
| EP (1) | EP4178976A1 (https=) |
| JP (1) | JP2023534241A (https=) |
| KR (1) | KR20230043881A (https=) |
| CN (1) | CN116322734A (https=) |
| AU (1) | AU2021310213A1 (https=) |
| CA (1) | CA3185241A1 (https=) |
| WO (1) | WO2022015694A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022227029A1 (en) | 2021-02-26 | 2023-08-31 | New York University | Compositions and methods comprising antibodies that bind to covalent peptide conjugates |
| CN118852403A (zh) * | 2023-04-26 | 2024-10-29 | 北京鼎成肽源生物技术有限公司 | 靶向kras突变的tcr分子和细胞及其应用 |
| CN120157754A (zh) * | 2023-12-14 | 2025-06-17 | 新景智源生物科技(苏州)有限公司 | Kras_g12d突变抗原特异性tcr及其与cd8共表达重定向cd4 t细胞 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL150732A0 (en) * | 2000-01-14 | 2003-02-12 | Corixa Corp | Prostate specific polypeptides, polynucleotides that encode said polypeptides and pharmaceutical compositions containing the same |
| AU2003265948B8 (en) | 2002-09-06 | 2009-09-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| WO2012129201A1 (en) | 2011-03-22 | 2012-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| WO2018026691A1 (en) * | 2016-08-02 | 2018-02-08 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-kras-g12d t cell receptors |
| CN108395479B (zh) * | 2017-02-06 | 2021-07-16 | 高军 | 一种有关kras基因突变的t细胞受体 |
| EP3684799A1 (en) * | 2017-09-20 | 2020-07-29 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Hla class ii restricted t cell receptors against mutated ras |
-
2021
- 2021-07-13 WO PCT/US2021/041375 patent/WO2022015694A1/en not_active Ceased
- 2021-07-13 AU AU2021310213A patent/AU2021310213A1/en active Pending
- 2021-07-13 KR KR1020237004523A patent/KR20230043881A/ko active Pending
- 2021-07-13 CA CA3185241A patent/CA3185241A1/en active Pending
- 2021-07-13 JP JP2023502572A patent/JP2023534241A/ja active Pending
- 2021-07-13 US US18/015,776 patent/US20230272038A1/en active Pending
- 2021-07-13 CN CN202180061706.7A patent/CN116322734A/zh active Pending
- 2021-07-13 EP EP21751702.8A patent/EP4178976A1/en active Pending